The biotech drug developer said Monday that it will pay $116.50 in cash for each share ... Crews find 4th victim from blast at San Antonio company.
News
- Amgen to buy Horizon Therapeutics in $26.4B deal - MyNorthwest.com
- Texas-Squared Startup Newsletter #379 | by Marc Nathan | Dec, 2022 - Medium
KXAN; San Antonio's Rackspace is Grappling with a Ransomware Attack — Link ... Southlake Biotech Renibus Therapeutics Garners $33M in Bridge ...
- Angle PLC Announces Two Parsortix Posters Presented at SABCS - BioSpace
... at the San Antonio Breast Cancer Symposium (SABCS), in San Antonio, ... The laboratories offer services globally to pharmaceutical and biotech ...
- New data on breast cancer candidate sends Ambrx Biopharma skyward - The Pharma Letter
... data from its Phase II ACE‑Breast-03 study during a Spotlight Poster Presentation at the 2022 San Antonio Breast Cancer Symposium (SABCS).
- MonarchE Update Benefit of Abemaciclib Increases Over Time - The ASCO Post
... the data at the 2022 San Antonio Breast Cancer Symposium (Abstract GS1-09). ... Eisai, AstraZeneca, Roche, Eli Lilly, and Puma Biotechnology.